Rapid clinical fluorescence immunoassay
test kits for RF
Methodology
Fluorescence Immunoassay
Product show
Size:15.5cm x 16.5cm x 7.5cm
25pcsx30boxes/carton
The rheumatoid factor (RF) test is primarily used to help diagnose rheumatoid arthritis (RA) and to
help distinguish RA from other forms of arthritis or other conditions that
cause similar symptoms.
While diagnosis of RA relies heavily on the clinical picture, some of the signs and symptoms may not
be present or follow a typical pattern, especially
early in the disease. Furthermore, the signs and symptoms may not always be clearly
identifiable since people with RA may also have other connective tissue disorders or conditions,
such as Raynaud phenomenon, scleroderma, autoimmune thyroid disorders, and
systemic lupus erythematosis, and display symptoms
of these disorders as well.
The RF test is one tool among others that can be used to help make a diagnosis when
RA is suspected.
The RF test must be interpreted in conjunction with a person's symptoms and clinical history.
In those with symptoms and clinical signs of rheumatoid arthritis, the presence of significant concentrations of RF indicates that it is likely that they have RA. Higher levels of RF generally correlate with more severe disease and a poorerprognosis.
A negative RF test does not rule out RA. About 20% of people with RA will have very low levels of or no detectable RF. In these cases, a CCP antibody test may be positive and used to confirm RA.
Positive RF test results may also be seen in 1-5% of healthy people and in some people
with conditions such as: Sjögren syndrome, scleroderma, systemic lupus erythematosus (lupus), sarcoidosis, endocarditis, tuberculosis, syphilis,HIV/AIDS, hepatitis, infectious
mononucleosis, cancers such as leukemia and multiple myeloma, parasitic infection, or
disease of the liver, lung, or kidney. The RF test is not used to diagnose or monitor these
other conditions.
Inflammation/Infection
PCT(whole blood), PCT (surum), hs-CRP
Cardiovascular
NT-proBNP, D-Dimer
cTnI,CK-MB, MYO
Nephropathy
NAGL, RBP,Cys-c, mAlb, B2-MG
Gastrosis
PGⅠ/ PGⅡ/ PGR/ HP/ FOB
Rheumatism
RF
Diabetes
C-Peptide
The British general consul stationed in Shanghai lead foreig
In order to promote international technology transfer and cooperation, strengthen the effective docking between high-tech enterprises and the British innovation resources , facilitate more overseas advanced technology which meet the needs of development
of local industry to land in Nanjing and realize industrialization, In the afternoon of
March 23 , the leaders of high-tech district and British general consul stationed in
Shanghai led foreign entrepreneurs to visit Norman, president of Norman and other leadership provided the visitors warm reception.
Foreign entrepreneurs delegation first visited our office management area, knew about Norman core organization structure and function. Subsequently the delegation went to
R&D center for exchanging. Responsible person of R & D Center introduced the development process of our products in detail to the members of the delegation.
Norman adheres to the independent research and development production of antigen
and antibody, this attitude let delegation feel deeply Norman's strong R & D strength
and spirit of rigorous attention. The delegation carefully inquired every items and
platform, The PCT items contained in chemiluminescence platform, is peripheral
blood detection, high accuracy, small volume, impressed the delegation and coursed
them to get great interest.
Agent Wanted
If you are interested in working with us, please feel free to contact.
